Name | 3-[5-(4-Fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-6-methoxy-quinolin-2-ol |
---|---|
Synonyms |
2(1H)-Quinolinone, 3-[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]-6-methoxy-
3-[5-(4-Fluorophenyl)-1,2,4-oxadiazol-3-yl]-6-methoxy-2(1H)-quinolinone 3-[5-(4-Fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-6-methoxy-quinolin-2-ol |
Description | NCGC00029283 is a werner syndrome helicase-nuclease (WRN) helicase inhibitor with IC50s of 2.3 μM, 12.5 μM, and 3.4 μM for WRN, BLM and FANCJ helicase, respectively[1]. |
---|---|
Related Catalog | |
In Vitro | NCGC00029283 (0-100 μM; 24-72 h) effectively blocks cell proliferation in U2-OS cells[1]. Cell Proliferation Assay[1] Cell Line: U2-OS cells Concentration: 1 μM, 10 μM, 100 μM Incubation Time: 24 h, 48 h, 72 h Result: Showed a reduction in U2-OS cell proliferation. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 576.7±60.0 °C at 760 mmHg |
Molecular Formula | C18H12FN3O3 |
Molecular Weight | 337.305 |
Flash Point | 302.6±32.9 °C |
Exact Mass | 337.086273 |
LogP | 5.61 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.647 |
Hazard Codes | Xi |
---|